SOUTH SAN FRANCISCO (dpa-AFX) - Switzerland-based healthcare major Roche (RO, ROG, RHHBY) on Thursday announced collaborations with Ibex Medical Analytics and Amazon Web Services, to accelerate adoption of AI-enabled digital pathology solutions that would help improve cancer diagnoses.
The collaboration would enable pathology laboratories to access Ibex's AI-powered decision support tools to support clinicians in breast and prostate cancer diagnosis through the navify Digital Pathology software platform.
Roche and Ibex cloud-based digital pathology and AI solutions run on Amazon Web Services (AWS), enabling a scalable and sustainable ecosystem for pathology laboratories.
Ibex's AI algorithms would help clinicians in the diagnosis of breast and prostate biopsies and provide efficient, accurate and timely cancer diagnosis, support case prioritization, determine the cancer grading and subtype, and identify important non-cancerous features.
The Ibex algorithms used at laboratories and hospitals worldwide, are currently for Research Use Only, not for use in diagnostic procedures, in the United States, and CE-Marked for IVD use in Europe for breast and prostate cancer detection in multiple workflows.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2023 AFX News